Ovarian Cancer Surgeon Echoes Recent American Cancer Society Findings

Armen Hareyan's picture

Ovarian Cancer Institute in Atlanta echoes findings in a report issued from the American Cancer Society, Gynecologic Cancer Foundation and the Society of Gynecologic Oncologists.

"I am pleased to see that ovarian cancer is receiving the critical attention it deserves regarding early warning symptoms that so many are unaware of," explained Benedict B. Benigno, M.D. "We have always maintained that women should, indeed, pay attention to their bodies and that there are warning signs of ovarian cancer, and certain groups of women are also pre-disposed to this deadly disease," he continued.


Ovarian Cancer Institute, located on campus of Georgia Institute of Technology in Atlanta, has been working since 1999 to discover an early detection tool for ovarian cancer, and in fact, the discovery of a reliable test is the organization's number-one mission. "My colleague, John McDonald, PhD, leads our credentialed research team in studying 300-plus ovarian tumor samples a year, as we inch closer to finding an early detection test. OCI studies more tumor samples per year than any other medical institution in the country," explained Dr. Benigno.

OCI has made significant strides in the treatment of advanced cases of ovarian cancer, using groundbreaking chemotherapy combinations that have worked successfully for many of Dr. Benigno's patients, some of whom were deemed terminal by other doctors. Additionally, OCI released findings in May regarding a gene (p53) that plays a crucial role in interacting with cancer cells treated by chemotherapy."

Each day brings us closer to a reliable early detection tool and new chemo combinations that we can use to save the lives of women wrought with this deadly disease. In the meantime, we work tirelessly to educate women across the world about risk factors and symptoms that, if they learn to recognize, could very well save their lives," commented Dr. Benigno.